Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth.

Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth. Abstract Text:

Dawn Webber,Allen L Rodgers,Edward D Sturrock,

Urinary glycoproteins play an important role in the modulation of calcium oxalate crystallisation. In several cases, this has been attributed to glycosylation of the proteins as evidenced by urinary prothrombin fragment 1 where there is a correlation between sialylation and calcium oxalate kidney stone disease. In the present study, plasma-derived prothrombin fragment 1 (PTF1) was enzymatically modified in order to generate its asialo and aglyco forms. The parent glycoprotein and its two glycoforms were used in calcium oxalate crystallisation studies to assess the role of the carbohydrate moeity in PTF1's potent inhibitory activity. The glycans inhibited crystal aggregation and promoted crystal nucleation, but had no effect on crystal growth. The terminal sialic acid residues had a small effect on inhibition of crystal aggregation whereas they contributed significantly to promotion of nucleation. These results indicate that glycosylation of PTF1 governs calcium oxalate crystal nucleation and aggregation but it does not affect the protein's role in inhibiting crystal growth. Since promotion of nucleation and inhibition of aggregation are both regarded as protective mechanisms against calcium oxalate urinary stone formation, the kringle domain on which the glycans are located is implicated in PTF1's inhibitory activity. It is speculated that modifications in the glycosylation of urinary PTF1 in stone-formers may regulate its capacity to protect against calcium urolithiasis.

Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth. Publishing Authors By Initials

D Webber,AL Rodgers,ED Sturrock,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Urological research

VOLUME: 35

Page Numbers: 277-85

Journal Abbreviation: Urol. Res.

ISSN: 0300-5623

DAY: 7

MONTH: 11

YEAR: 2007

Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 364311

Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth.

AFFILIATION: Department of Chemistry, University of Cape Town, Private Bag, Rondebosch, Cape Town, 7701, South Africa, Dawn.Webber@uct.ac.za.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Urol Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth Related Publications

• A cluster randomised controlled trial of the effect of a treatment algorithm for hypertension in patients with type 2 diabetes.
• Angiotensin receptor blockers reduce erythrocyte sedimentation rate levels in patients with rheumatoid arthritis.
• Ankylosing spondylitis.
• Autonomic neuropathy in rheumatoid arthritis.
• Autonomic neuropathy in the Guillain-Barré syndrome.
• Eye shield with removable lid.
• Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth.
• Gout is a risk factor for cardiovascular disease.
• Health problems of anaesthetists and their families.
• Lattice corneal dystrophy: a source of confusion.
• Medically qualified preclinical academics.
• Medically qualified preclinical academics.
• Musculoskeletal reflex function in the joint hypermobility syndrome.
• Nocturnal lagophthalmos and recurrent erosion.
• Observations on the susceptibility to Schistosoma mansoni from St. Lucia of several Caribbean strains of snails of the genus Biomphalaria.
• Probing the basis of domain-dependent inhibition using novel ketone inhibitors of Angiotensin-converting enzyme.
• THE CONTROL OF TRICHOSTRONGYLE LARVAE (NEMATODA) BY FUMIGATION IN RELATION TO THEIR BIONOMICS. II. LABORATORY TOXICITY TESTS WITH METHYL BROMIDE.
• The role of glycosylation and domain interactions in the thermal stability of human angiotensin-converting enzyme.
• The use and abuse of Distalgesic.
• Unintended benefits of immunosupression on autoimmune disease due to chemoradiation therapy for head and neck cancer.